NCT03817671 is a NA clinical trial of 5% O2 in Embryo Development, sponsored by Ganin Fertility Center.

Who is sponsoring NCT03817671?

NCT03817671 is sponsored by Ganin Fertility Center.

What drugs are being tested in NCT03817671?

Interventions in NCT03817671: 5% O2, 2% O2.

What condition does NCT03817671 study?

NCT03817671 studies Embryo Development.

Is NCT03817671 still recruiting?

NCT03817671 is currently status unknown. Last updated 28 January 2019.

Last reviewed 2019-01-28 · How we verify

NCT03817671

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Clinical Outcome of Ultra-low Oxygen Tension on Post Thawed Human Blastocyst

Status unknown NA Last updated 28 January 2019

What this trial tests

NA trial testing 5% O2 in Embryo Development in 168 participants. Status unknown.

Timeline

20 November 2018

Primary endpoint
30 June 2020

30 June 2020

Quick facts

Lead sponsor	Ganin Fertility Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	168
Start date	20 November 2018
Primary completion	30 June 2020
Estimated completion	30 June 2020
Sites	1 location across Egypt

Drugs / interventions tested

5% O2 — full drug profile →
2% O2

Conditions studied

Embryo Development — all drugs for Embryo Development →

Sponsor

Ganin Fertility Center

Who can join

Adults 5 Days to 6 Days, any sex, with Embryo Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The clinical outcome of Ultra-low oxygen tension on post thawed human blastocyst

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Embryo Development

Currently open trials in the same condition.

NCT07500337 — Day-4 Embryo Defragmentation: Blastocyst Rate and clInical Outcomes · NA · recruiting

Other Ganin Fertility Center trials

Trials by the same sponsor.

NCT06850909 — Evaluating the Influence of 3D Culture Dish Design on Preimplantation Genetic Development in Sibling Oocytes: a Randomiz · NA · not yet recruiting
NCT06476379 — Can the Origin of Sperm Affect Embryo Ploidy in Patients With Severe Male Factor Infertility? · NA · completed
NCT06231589 — PGT-A Evaluates Advanced Sperm Selection in Embryos From High Teratozoospermia Males · NA · completed
NCT05499988 — The Importance of Blastocyst Diamater and Its Correlation to Reproductive Outcomes in PGT-A Cases · unknown
NCT05494216 — Advanced Sperm Selection Techniques and Their Contribution to Blastocyst Euploidy Rates · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03817671 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ganin Fertility Center
Last refreshed: 28 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03817671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing